Does GILTERITINIB Cause Platelet count decreased? 327 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 327 reports of Platelet count decreased have been filed in association with GILTERITINIB (Xospata). This represents 8.9% of all adverse event reports for GILTERITINIB.
327
Reports of Platelet count decreased with GILTERITINIB
8.9%
of all GILTERITINIB reports
61
Deaths
139
Hospitalizations
How Dangerous Is Platelet count decreased From GILTERITINIB?
Of the 327 reports, 61 (18.7%) resulted in death, 139 (42.5%) required hospitalization, and 23 (7.0%) were considered life-threatening.
Is Platelet count decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GILTERITINIB. However, 327 reports have been filed with the FAERS database.
What Other Side Effects Does GILTERITINIB Cause?
Acute myeloid leukaemia (366)
Febrile neutropenia (346)
Off label use (334)
Pneumonia (302)
Myelosuppression (300)
Pyrexia (281)
Death (206)
Product use issue (189)
Hepatic function abnormal (181)
Neutrophil count decreased (162)
What Other Drugs Cause Platelet count decreased?
LENALIDOMIDE (7,491)
NIRAPARIB (4,102)
ELTROMBOPAG OLAMINE (3,419)
RUXOLITINIB (3,028)
RITUXIMAB (2,404)
VENETOCLAX (2,367)
DEXAMETHASONE (2,321)
PALBOCICLIB (2,277)
CYCLOPHOSPHAMIDE (1,894)
RIBAVIRIN (1,701)
Which GILTERITINIB Alternatives Have Lower Platelet count decreased Risk?
GILTERITINIB vs GIMERACIL\OTERACIL\TEGAFUR
GILTERITINIB vs GINKGO
GILTERITINIB vs GIVINOSTAT
GILTERITINIB vs GIVOSIRAN
GILTERITINIB vs GLASDEGIB